Analyst
ICICI Securities
Equibles does not estimate personal net worth.
Shubh Mehta is recorded as Analyst at ICICI Securities. Shubh Mehta has spoken on 3 earnings calls across 3 companies, most recently for Piramal Pharma Limited on October 28, 2026. Those appearances were for Piramal Pharma Limited, Nephrocare Health Services Limited and Alivus Life Sciences Limited. The companies whose calls Shubh Mehta spoke on are classified in the Healthcare sector.
“Sir, if we can dissect the growth in CDMO. The growth is from commercialization of phase 3 molecules, or is it the addition of phase 1, phase 2, or phase 3 molecules over there?”
“Sir, I wanted to understand the broad nature of 19 new clinics, which we added in India geography. Is it a green field or brown field or PPP sort of nature, if you can give us some sense over there?”
“So, building on to the question of previous participant on high potent molecule contribution, I wanted to understand. This year, we had 12 molecules which were there, and last year, if I see, the size was 7 molecules which were there, submitted and accepted.”
ICICI Securities
Analyst
Transcript header (unverified)
Piramal Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Nephrocare Health Services Limited
Medical Care Facilities · Healthcare
Alivus Life Sciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Piramal Pharma Limited
Earnings Call for the Quarter Ended June 30, 2026
Nephrocare Health Services Limited
Earnings Call for the Quarter Ended March 31, 2026
Alivus Life Sciences Limited
